Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: New Constructs, LLC
$25.00
Provider: Stock Traders Daily
$20.00
Provider: ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Procter & Gamble Co Reiterates FY 2014 Guidance


Friday, 25 Oct 2013 07:00am EDT 

Procter & Gamble Co reiterated its fiscal 2014 guidance and expect organic sales growth of 3% to 4%. All-in sales growth is estimated in the range of 1% to 2%, including a negative foreign exchange impact of approximately 2%. Core earnings per share (EPS) are expected to grow 5% to 7% for fiscal 2014 , and reported EPS are expected to grow in the range of 7% to 9%. Also, the Company noted that it expects the second quarter negative earnings impact from foreign exchange to be similar to what it was in the first quarter. The Company reported revenue of $84.2 billion and EPS of $3.86 in fiscal 2013. According to I/B/E/S Estimates, analysts on an average were expecting the Company to report revenue of $86 billion for fiscal 2014. 

Company Quote

84.16
0.08 +0.10%
17 Sep 2014